Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• A Quantitative Magnetic Resonance Cholangiopancreatography Metric of Intrahepatic Biliary Dilatation Severity Detects High-Risk Primary Sclerosing Cholangitis.1 passage
• Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes-Associated Protein 1 Activation and Transient Expansion of Stem-Like Cancer Cells.1 passage
• Adjunct Fenofibrate Up-regulates Bile Acid Glucuronidation and Improves Treatment Response For Patients With Cholestasis.1 passage
• Aiming for Functional Cure With Established and Novel Therapies for Chronic Hepatitis B.1 passage
• Alcohol-Associated Liver Disease Before and After COVID-19-An Overview and Call for Ongoing Investigation.1 passage
• Alcohol-Induced Liver Injury: Down-regulation and Redistribution of Rab3D Results in Atypical Protein Trafficking.1 passage
• An Analysis of Free-Text Refusals as an Indicator of Readiness to Accept Organ Offers in Liver Transplantation.1 passage
• Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy.1 passage
• Association Between Transient Elastography and Controlled Attenuated Parameter and Liver Ultrasound in Children With Cystic Fibrosis.1 passage
• Associations Between Alcohol Use and Liver-Related Outcomes in a Large National Cohort of Patients With Cirrhosis.1 passage
• Automated Measurements of Body Composition in Abdominal CT Scans Using Artificial Intelligence Can Predict Mortality in Patients With Cirrhosis.1 passage
• Bile Salt and FGF19 Signaling in the Early Phase of Human Liver Regeneration.1 passage
• COVID-19 Aftershocks on Alcohol-Associated Liver Disease: An Early Cross-Sectional Report From the U.S. Epicenter.1 passage
• COVID-19 and the Uncovering of Health Care Disparities in the United States, United Kingdom and Canada: Call to Action.1 passage
• COVID-19-Related Downscaling of In-Hospital Liver Care Decreased Patient Satisfaction and Increased Liver-Related Mortality.1 passage
• Clinical Staging of Mass-Forming Intrahepatic Cholangiocarcinoma: Computed Tomography Versus Magnetic Resonance Imaging.1 passage
• Cluster of Differentiation 44 Promotes Liver Fibrosis and Serves as a Biomarker in Congestive Hepatopathy.1 passage
• Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma.1 passage
• Cognitive Impairment and Physical Frailty in Patients With Cirrhosis.1 passage
• Community Socioeconomic Deprivation Predicts Nonalcoholic Steatohepatitis.1 passage
• Correlation Between Clinical and Pathological Findings of Liver Injury in 27 Patients With Lethal COVID-19 Infections in Brazil.1 passage
• Covid-19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis.1 passage
• Current and Emerging Tools for Hepatocellular Carcinoma Surveillance.1 passage
• DNA Methylation Markers for Detection of Cholangiocarcinoma: Discovery, Validation, and Clinical Testing in Biliary Brushings and Plasma.1 passage
• Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update.1 passage
• Detection of Hepatitis B Virus-Host Junction Sequences in Urine of Infected Patients.1 passage
• Deuterium-Stabilized (1 passage
• Dietary Risks for Liver Mortality in NAFLD: Global Burden of Disease Data.1 passage
• Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis.1 passage
• Distinct Hepatic Gene-Expression Patterns of NAFLD in Patients With Obesity.1 passage
• Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study.1 passage
• Enhancing Linkage to Hepatitis C Virus Treatment Following Pregnancy in Women Identified During Perinatal Care.1 passage
• Fatty Liver Is an Independent Risk Factor for Delayed Recovery from Anesthesia.1 passage
• Fatty Liver and the Coronavirus Disease 2019 Pandemic: Health Behaviors, Social Factors, and Telemedicine Satisfaction in Vulnerable Populations.1 passage
• Fibrosis-4 Predicts the Need for Mechanical Ventilation in a National Multiethnic Cohort of Corona Virus Disease 2019.1 passage
• Frailty and Sarcopenia in Acute-on-Chronic Liver Failure.1 passage
• Frailty and the Risk of Acute Kidney Injury Among Patients With Cirrhosis.1 passage
• Genome-Wide Association Study of NAFLD Using Electronic Health Records.1 passage
• Globo H Is a Promising Theranostic Marker for Intrahepatic Cholangiocarcinoma.1 passage
• HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis Delta.1 passage
• Health-Related Quality of Life and Its Contributors According to a Preference-Based Generic Instrument in Cirrhosis.1 passage
• Hepatic NF-κB-Inducing Kinase and Inhibitor of NF-κB Kinase Subunit α Promote Liver Oxidative Stress, Ferroptosis, and Liver Injury.1 passage
• Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis.1 passage
• Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus.1 passage
• Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis.1 passage
• Hepatocyte Nuclear Factor 4 alpha 2 Messenger RNA Reprograms Liver-Enriched Transcription Factors and Functional Proteins in End-Stage Cirrhotic Human Hepatocytes.1 passage
• Heterozygosity of the Alpha 1-Antitrypsin Pi*Z Allele and Risk of Liver Disease.1 passage
• High Effectiveness of Broad Access Direct-Acting Antiviral Therapy for Hepatitis C in an Australian Real-World Cohort: The REACH-C Study.1 passage
• High Prevalence of Transjugular Intrahepatic Portosystemic Shunt Creation Without Prior Endoscopy During Acute Variceal Bleeding Hospitalization in the United States.1 passage
• High-Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases.1 passage
• Impact of COVID-19 in Liver Disease Progression.1 passage
• Impact of Nuclear Factor Erythroid 2-Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status.1 passage
• Impact of Obeticholic acid Exposure on Decompensation and Mortality in Primary Biliary Cholangitis and Cirrhosis.1 passage
• Impact of Platelet Count on Perioperative Bleeding in Patients With Cirrhosis Undergoing Surgical Treatments of Liver Cancer.1 passage
• Inclusive Quantification Assay of Serum Des-γ-Carboxyprothrombin Proteoforms for Hepatocellular Carcinoma Surveillance by Targeted Mass Spectrometry.1 passage
• Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID-19 Infection.1 passage
• Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation.1 passage
• Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell-Mediated Antitumor Immunity Through PD-L1.1 passage
• Inhibition of Drug-Induced Liver Injury in Mice Using a Positively Charged Peptide That Binds DNA.1 passage
• Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population.1 passage
• Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD.1 passage
• Leukocyte-Derived High-Mobility Group Box 1 Governs Hepatic Immune Responses to Listeria monocytogenes.1 passage
• Lipidomics and Redox Lipidomics Indicate Early Stage Alcohol-Induced Liver Damage.1 passage
• Liver Cancer Has a Distinctive Profile in Black Patients: Current Screening Guidelines May Be Inadequate.1 passage
• Liver Disease and Risk of Hepatocellular Carcinoma in Children With Mutations in TALDO1.1 passage
• Liver Fibrosis Index FIB-4 Is Associated With Mortality in COVID-19.1 passage
• Liver Injury as a Surrogate for Inflammation and Predictor of Outcomes in COVID-19.1 passage
• Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019.1 passage
• Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.1 passage
• Low Serum Cholinesterase Identifies Patients With Worse Outcome and Increased Mortality After TIPS.1 passage
• Mandatory Hepatology Education for Internal Medicine Residents: Long-Term Effects and Implications for Workforce Needs.1 passage
• Molecular Imaging of Tumor Microenvironment to Assess the Effects of Locoregional Treatment for Hepatocellular Carcinoma.1 passage
• More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC.1 passage
• Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation.1 passage
• Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control Study.1 passage
• MutT Homolog 1 Inhibitor Karonudib Attenuates Autoimmune Hepatitis by Inhibiting DNA Repair in Activated T Cells.1 passage
• Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the United States, 2007-2016.1 passage
• Obeticholic Acid Decreases Intestinal Content of Enterococcus in Rats With Cirrhosis and Ascites.1 passage
• Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA.1 passage
• PRO-C3, a Serological Marker of Fibrosis, During Childhood and Correlations With Fibrosis in Pediatric NAFLD.1 passage
• PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and1 passage
• Palliative Care Always: Hepatology-Virtual Primary Palliative Care Training for Hepatologists.1 passage
• Perceptions of Exercise and Its Challenges in Patients With Nonalcoholic Fatty Liver Disease: A Survey-Based Study.1 passage
• Poor Awareness of Liver Disease Among Adults With NAFLD in the United States.1 passage
• Predicting Liver-Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests.1 passage
• Predictors of Jaundice Resolution and Survival After Endoscopic Treatment of Primary Sclerosing Cholangitis.1 passage
• Presence of Liver Inflammation in Asian Patients With Chronic Hepatitis B With Normal ALT and Detectable HBV DNA in Absence of Liver Fibrosis.1 passage
• Prevalence of High Liver Stiffness and a Screening Strategy Using the SODA-2B Score Among US Adults.1 passage
• Proposal and Validation of a Novel Scoring System for Hepatocellular Carcinomas Beyond Curability Borders.1 passage
• Prospective Study of Withdrawal of Antiviral Therapy in Patients with Chronic Hepatitis B after Prolonged Virological Response.1 passage
• Protective Effects of Statin Therapy in Cirrhosis Are Limited by a Common SLCO1B1 Transporter Variant.1 passage
• Racial, Ethnic, and Socioeconomic Disparities in Curative Treatment Receipt and Survival in Hepatocellular Carcinoma.1 passage
• Reassessment of the Hispanic Disparity: Hepatic Steatosis Is More Prevalent in Mexican Americans Than Other Hispanics.1 passage
• Risk Prediction of Nosocomial and Posthospital Discharge Infections in Alcohol-Associated Hepatitis.1 passage
• Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.1 passage
• Risks and Benefits of Discontinuation of Nucleos(t)ide Analogue Treatment: A Treatment Concept for Patients With HBeAg-Negative Chronic Hepatitis B.1 passage
• Role of Cholesterol-Associated Steatohepatitis in the Development of NASH.1 passage
• Role of Hepatocyte-Derived Osteopontin in Liver Carcinogenesis.1 passage
• SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 Vaccination.1 passage
• Severe Alcohol-Associated Hepatitis Is Associated With Worse Survival in Critically Ill Patients With Acute on Chronic Liver Failure.1 passage
• Shelter-Based Integrated Model Is Effective in Scaling Up Hepatitis C Testing and Treatment in Persons Experiencing Homelessness.1 passage
• Short-Term Safety of Repeated Acetaminophen Use in Patients With Compensated Cirrhosis.1 passage
• TGFβ-induced FOXS1 controls epithelial-mesenchymal transition and predicts a poor prognosis in liver cancer.1 passage
• The Matrisome Genes From Hepatitis B-Related Hepatocellular Carcinoma Unveiled.1 passage
• Therapeutic Underuse and Delay in Hepatocellular Carcinoma: Prevalence, Associated Factors, and Clinical Impact.1 passage
• Transcriptional Analysis of Liver Tissue Identifies Distinct Phenotypes of Indeterminate Pediatric Acute Liver Failure.1 passage
• Transcriptome and Exome Analyses of Hepatocellular Carcinoma Reveal Patterns to Predict Cancer Recurrence in Liver Transplant Patients.1 passage
• Transcriptomic Cross-Species Analysis of Chronic Liver Disease Reveals Consistent Regulation Between Humans and Mice.1 passage
• Ultrasensitive Assay for Hepatitis B Core-Related Antigen Predicts Hepatocellular Carcinoma Incidences During Entecavir.1 passage
• Usefulness of Cell-Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment Efficacy.1 passage
• Usefulness of the Stroop Test in Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy.1 passage
• Validation of Dynamic Aspartate-to-Alanine Aminotransferase Ratio for Predicting Liver Disease Mortality.1 passage
• What Does the Future Hold for Patients With Nonalcoholic Steatohepatitis: Diagnostic Strategies and Treatment Options in 2021 and Beyond?1 passage
• Wilson's Disease: An Analysis of Health Care Use and Cost Burden of Commercially Insured Adults in the United States.1 passage